PTC Therapeutics's total assets for Q3 2024 were $1.84B, a decrease of -3.87% from the previous quarter. PTCT total liabilities were $2.90B for the fiscal quarter, a <0.01% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.